Pyxis Oncology Inc
PYXS
Get informed when a big investor buys or sells
+ FollowMarket Cap$236.32M
Close$
$0.39
89.7% downside
Current Fair Value
89.7% downsideOvervalued by 89.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $236.32 Million |
|---|---|
| Enterprise Value | $247.33 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.28 |
| Beta | 1.31 |
| Outstanding Shares | 63,469,850 |
Return
| Return on Equity | -261.40% |
|---|---|
| Return on Assets | -127.12% |
| Return on Invested Capital | -181.38% |
Valuation & Multiples
| P/E Ratio | -2.85 |
|---|---|
| PEG | -28.5 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 17.85 |
| Enterprise Value to EBIT | -2.85 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.58 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$10.94 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.34
Average shareholder expectationRevenue Estimate
$33,333
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 23.10% |
|---|---|
| Total Calls | 134,900▼ 47.26% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 43.44%▼ 5.15% |
|---|---|
| Total Invested | $40.53M▲ 16.69% |
| Investors Holding | 810% |
ESG Score
No data